Back to Search
Start Over
ACTR-56. A 2-PART SAFETY AND EXPLORATORY EFFICACY RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A 1:1 RATIO OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL (CBD:THC) PLUS DOSE-INTENSE TEMOZOLOMIDE IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (GBM)
- Publication Year :
- 2017
- Publisher :
- Oxford University Press, 2017.
- Subjects :
- 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
Randomization
Temozolomide
business.industry
Cmax
Placebo-controlled study
Double blind
03 medical and health sciences
Abstracts
030104 developmental biology
Internal medicine
Delta-9-tetrahydrocannabinol
medicine
In patient
Neurology (clinical)
business
Cannabidiol
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....f696a0ca52aba3449bc534c286657e7a